WntResearch on the revised study plan for the NeoFox-study
WntResearch has published unexpected discoveries in the NeoFox study during the fall. In an interview from the BioStock Life Science Summit, the company’s CEO Pernilla Sandwall and co-founder Tommy Andersson tells us about the new discoveries with candidate Foxy-5, the updated study plan and the upcoming rights issue.
See the interview with WntResearchs CEO Pernilla Sandwall and co-founder Professor Tommy Andersson here.
The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.
